Suppr超能文献

α1肾上腺素能受体药理学的最新进展。

Recent advances in alpha1-adrenoceptor pharmacology.

作者信息

Koshimizu Taka-aki, Tanoue Akito, Hirasawa Akira, Yamauchi Junji, Tsujimoto Gozoh

机构信息

Department of Molecular Cell Pharmacology, National Research Institute for Child Health and Development, 3-35-31, Taishi-do, Setagaya-ku, 154, Tokyo, Japan.

出版信息

Pharmacol Ther. 2003 May;98(2):235-44. doi: 10.1016/s0163-7258(03)00033-0.

Abstract

alpha(1)-Adrenergic receptors (ARs) mediate some of the main actions of the natural catecholamines, adrenaline and noradrenaline. They participate in many essential physiological processes, such as sympathetic neurotransmission, modulation of hepatic metabolism, control of vascular tone, cardiac contraction, and the regulation of smooth muscle activity in the genitourinary system. Here, we review recent progress on subtype-specific subcellular localization, participation in signaling cascades, and the pivotal function of alpha(1)-ARs, as delineated through studies on genetically engineered animals. Together, these findings will provide new insights into the physiological and pathophysiological roles of the alpha(1)-ARs.

摘要

α1肾上腺素能受体(ARs)介导天然儿茶酚胺、肾上腺素和去甲肾上腺素的一些主要作用。它们参与许多重要的生理过程,如交感神经传递、肝脏代谢调节、血管张力控制、心脏收缩以及泌尿生殖系统平滑肌活动的调节。在此,我们综述了通过对基因工程动物的研究所描绘的α1-ARs亚型特异性亚细胞定位、参与信号级联反应以及关键功能方面的最新进展。这些发现共同将为α1-ARs的生理和病理生理作用提供新的见解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验